2024

• August 23rd Smalley Lab at ASCO SNO 2024 Brain Mets Conference

• April 5-10th Larissa presented her research on pan-RAS inhibitors in NRAS-mutant melanoma models at AACR

• March 23rd  Smalley Lab at Uveal Melanoma Retreat for MPI R01 group

2023

• November 29th Recent publication in nature communications titled, 'HDAC-8 mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis'

2020

• September 2nd  Press release: our recent publication in Journal of Investigative Dermatology where we identified non-canonical EphA2 signaling is a driver of the BRAF inhibitor-resistant melanoma

• January 10th  Press release: our recent publication in Clinical Cancer Research where we analyzed protein expression markers in CSF from patients with leptomeningeal disease

2019

• October 8th  Press release: using an adaptive dosing schedule for BRAFi therapy prolongs drug sensitivity in melanoma by maintaining diverse tumor cell populations

• July 8th Press release: our publication in Clinical Cancer Research where preclinical studies reveal the impact of HDAC inhibitors in uveal melanoma